









市場行情
/
股票
/
nasdaq-slp
/

Simulations Plus Inc

SLP

14.100USD

-0.470-3.23%

收盤 02/09, 16:00（美東）報價延遲15分鐘

219.58M總市值

虧損本益比TTM



Simulations Plus Inc

14.100

-0.470-3.23%

概覽財務分析公司

概覽

財務

分析

公司

關於 Simulations Plus Inc 公司

Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.

Simulations Plus Inc簡介



公司代碼SLP

公司名稱Simulations Plus Inc

上市日期Jun 18, 1997

CEOO'Connor (Shawn M)

員工數量212

證券類型Ordinary Share

年結日Jun 18

公司地址800 Park Offices Drive, Suite 401

城市RESEARCH TRIANGLE PARK

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編27709

電話16617237723

網址https://www.simulations-plus.com/

公司代碼SLP

上市日期Jun 18, 1997

CEOO'Connor (Shawn M)

Simulations Plus Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Dr. Hon. Walter S. Woltosz

Independent Director

3.28M

+1776.00%

Ms. Jill Fiedler-Kelly

Interim President - Services Solutions

77.82K

+8950.00%

Ms. Sharlene Evans

Independent Director

15.06K

+1776.00%

Dr. John Kenneth Paglia, Ph.D.

Independent Director

12.47K

+1776.00%

Mr. John A. Dibella

Chief Revenue Officer

Dr. Daniel L. Weiner

Non-Executive Chairman of the Board

Mr. Shawn M. O'Connor

Chief Executive Officer

Dr. Lisa Lavange

Independent Director

Mr. William (Will) Frederick

Chief Financial Officer, Executive Vice President

Dr. Jonathan Chauvin

Co-Chief Product and Technology Officer

名稱

名稱/職務

職務

持股

持股變動

Dr. Hon. Walter S. Woltosz

Independent Director

3.28M

+1776.00%

Ms. Jill Fiedler-Kelly

Interim President - Services Solutions

77.82K

+8950.00%

Ms. Sharlene Evans

Independent Director

15.06K

+1776.00%

Dr. John Kenneth Paglia, Ph.D.

Independent Director

12.47K

+1776.00%

Mr. John A. Dibella

Chief Revenue Officer

Dr. Daniel L. Weiner

Non-Executive Chairman of the Board

收入明細

單位: USD更新時間: 1月6日週二

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Software licenses

45.83M

57.88%

Consulting services

33.35M

42.12%

地區USD

名稱

營收

佔比

Americas

57.70M

72.87%

Europe

14.19M

17.92%

Asia

7.29M

9.20%

業務

地區

業務USD

名稱

營收

佔比

Software licenses

45.83M

57.88%

Consulting services

33.35M

42.12%

股東統計

更新時間: 2月5日週四

持股股東

股東類型

持股股東

佔比

Woltosz (Walter S)

16.28%

BlackRock Institutional Trust Company, N.A.

5.29%

The Vanguard Group, Inc.

5.02%

Morgan Stanley & Co. LLC

4.13%

First Light Asset Management, LLC

3.81%

其他

65.47%

持股股東

佔比

Woltosz (Walter S)

16.28%

BlackRock Institutional Trust Company, N.A.

5.29%

The Vanguard Group, Inc.

5.02%

Morgan Stanley & Co. LLC

4.13%

First Light Asset Management, LLC

3.81%

其他

65.47%

股東類型

持股股東

佔比

Investment Advisor

36.70%

Investment Advisor/Hedge Fund

22.17%

Individual Investor

17.33%

Hedge Fund

10.72%

Research Firm

8.85%

Pension Fund

0.49%

Bank and Trust

0.21%

Venture Capital

0.11%

Insurance Company

0.03%

其他

3.38%

機構持股



更新時間: 1月1日週四

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

414

15.97M

79.29%

-4.03M

2025Q3

399

15.45M

76.77%

-3.13M

2025Q2

397

20.10M

99.87%

-2.39M

2025Q1

405

20.80M

103.44%

-1.07M

2024Q4

395

19.75M

98.32%

-353.54K

2024Q3

400

19.32M

96.55%

-155.06K

2024Q2

401

20.11M

100.50%

-787.76K

2024Q1

398

20.05M

100.34%

-310.16K

2023Q4

390

19.56M

97.97%

-570.84K

2023Q3

390

19.23M

96.46%

-1.16M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Woltosz (Walter S)

3.28M

16.28%

-9.10K

-0.28%

Dec 18, 2025

BlackRock Institutional Trust Company, N.A.

1.06M

5.29%

-1.18M

-52.66%

Sep 30, 2025

The Vanguard Group, Inc.

974.48K

4.84%

-197.15K

-16.83%

Sep 30, 2025

Morgan Stanley & Co. LLC

832.51K

4.13%

+582.97K

+233.61%

Sep 30, 2025

First Light Asset Management, LLC

767.76K

3.81%

+410.60K

+114.96%

Sep 30, 2025

Rockefeller Capital Management

745.96K

3.7%

+366.80K

+96.74%

Sep 30, 2025

Columbia Threadneedle Investments (UK)

602.47K

2.99%

+884.00

+0.15%

Sep 30, 2025

Tributary Capital Management, LLC

568.49K

2.82%

+207.21K

+57.36%

Sep 30, 2025

Stephens Investment Management Group, LLC

392.84K

1.95%

+124.26K

+46.27%

Sep 30, 2025

Dimensional Fund Advisors, L.P.

410.85K

2.04%

-74.55K

-15.36%

Sep 30, 2025

持股ETF



更新時間: 12月2日週二

機構名稱

佔比

State Street SPDR FactSet Innovative Technolgy ETF

0.58%

Global X HealthTech ETF

0.31%

First Trust Active Factor Small Cap ETF

0.28%

First Trust Multi-Manager Small Cap Opportunities ETF

0.21%

Franklin Exponential Data ETF

0.12%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

0.09%

Principal U.S. Small-Cap ETF

0.07%

iShares Micro-Cap ETF

0.06%

iShares Russell 2000 Growth ETF

0.02%

Proshares Ultra Russell 2000

0.01%

State Street SPDR FactSet Innovative Technolgy ETF

佔比0.58%

Global X HealthTech ETF

佔比0.31%

First Trust Active Factor Small Cap ETF

佔比0.28%

First Trust Multi-Manager Small Cap Opportunities ETF

佔比0.21%

Franklin Exponential Data ETF

佔比0.12%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

佔比0.09%

Principal U.S. Small-Cap ETF

佔比0.07%

iShares Micro-Cap ETF

佔比0.06%

iShares Russell 2000 Growth ETF

佔比0.02%

Proshares Ultra Russell 2000

佔比0.01%

分紅派息



近5年累計派現 19.26M 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

Jul 02, 2024

SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 05, 2024 going ex on Jul 29, 2024

Jul 29, 2024

Aug 05, 2024

Jul 29, 2024

Apr 03, 2024

SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 06, 2024 going ex on Apr 26, 2024

Apr 29, 2024

May 06, 2024

Apr 26, 2024

Jan 03, 2024

SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Feb 05, 2024 going ex on Jan 26, 2024

Jan 29, 2024

Feb 05, 2024

Jan 26, 2024

Oct 25, 2023

SLP.NB Final Cash Dividend of gross USD 0.06 paid on Nov 06, 2023 going ex on Oct 27, 2023

Oct 30, 2023

Nov 06, 2023

Oct 27, 2023

Jul 06, 2023

SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 07, 2023 going ex on Jul 28, 2023

Jul 31, 2023

Aug 07, 2023

Jul 28, 2023

Apr 06, 2023

SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 01, 2023 going ex on Apr 21, 2023

Apr 24, 2023

May 01, 2023

Apr 21, 2023

Jan 05, 2023

SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Feb 06, 2023 going ex on Jan 27, 2023

Jan 30, 2023

Feb 06, 2023

Jan 27, 2023

Oct 20, 2022

SLP.NB Final Cash Dividend of gross USD 0.06 paid on Nov 07, 2022 going ex on Oct 28, 2022

Oct 31, 2022

Nov 07, 2022

Oct 28, 2022

Jul 07, 2022

SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 01, 2022 going ex on Jul 22, 2022

Jul 25, 2022

Aug 01, 2022

Jul 22, 2022

Apr 06, 2022

SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 02, 2022 going ex on Apr 22, 2022

Apr 25, 2022

May 02, 2022

Apr 22, 2022

拆合股



公告日期

除權除息日

類型

比率

暫無數據

公告日期

除權除息日

類型

比率

暫無數據

KeyAI

